Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion for Chronic Pain in Opioid Dependent Patients
NCT02219321Phase 3Terminated
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2014
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in neuropathic pain (2 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Intensity of Pain. Started Dec 2014; status: terminated.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02219321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02219321.